Trials that use: Covariate adjustment
5,848 results
- Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage: Complete Statistical AnalysisIndependent statistical analysis of Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MANDALAA detailed statistical analysis of the phase 3 MANDALA trial of budesonide/albuterol metered-dose inhalers versus albuterol in adults and children 4 years of age or older with asthma, including time-to-event, rate, binary,…
- Manipulating the Gut Microbiome Study: Complete Statistical AnalysisIndependent statistical analysis of Manipulating the Gut Microbiome Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03181828).
- MankaiIndependent statistical analysis of Protein Bioavailability of Wolffia Globosa (Mankai); Acute Test Meal Effects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03020225).
- MANTAIndependent statistical analysis of Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease: primary endpoint results, effect estimate with confidence interval, sample-size…
- MAP-XIndependent statistical analysis of Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MAP4BUPIndependent statistical analysis of Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Marijuana in Combination With Opioids in Palliative and Hospice Patients: Complete Statistical AnalysisIndependent statistical analysis of Marijuana in Combination With Opioids in Palliative and Hospice Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03233633).
- MARRSIndependent statistical analysis of Millipede AspiRation for Revascularization in Stroke (MARRS) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05714501).
- MASHIndependent statistical analysis of Manual Therapy and Strengthening for the Hip in Older Adults With Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Massive Iron Deposit Assessment: Complete Statistical AnalysisIndependent statistical analysis of Massive Iron Deposit Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01572922).
- Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE: Complete Statistical AnalysisIndependent statistical analysis of Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MASTIndependent statistical analysis of MAST Trial: Multi-modal Analgesic Strategies in Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03472469).
- MASTIndependent statistical analysis of Study of the Mechanisms of Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00595153).
- MATCh-GDMIndependent statistical analysis of Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03029702).
- Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MATINEEAn independent statistical analysis of the phase 3 MATINEE trial of mepolizumab 100 mg versus placebo in COPD with frequent exacerbations and raised eosinophil levels, covering the negative binomial exacerbation-rate analysis, Cox…
- Mature B-Cell Lymphoma And Leukemia Study III: Complete Statistical AnalysisIndependent statistical analysis of Mature B-Cell Lymphoma And Leukemia Study III: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01046825).
- MAVISIndependent statistical analysis of Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation: Complete Statistical AnalysisIndependent statistical analysis of Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MAXIMIZAIndependent statistical analysis of Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza…
- MBMM+Independent statistical analysis of My Baby My Move A Community Wellness Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04294095).
- MBSRIndependent statistical analysis of Mindfulness-Based Stress Reduction for Adults With Low-Risk Chest Pain Associated With Anxiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- McCAVEIndependent statistical analysis of A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer: primary endpoint results, effect estimate with…
- MDDIndependent statistical analysis of Transcranial Alternating Current Stimulation for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02339285).
- MDs on Botox Utility (MOBILITY): Complete Statistical AnalysisIndependent statistical analysis of MDs on Botox Utility (MOBILITY): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00535938).
- Measurement of Relaxin Peptide in Multiple Sclerosis (MS): Complete Statistical AnalysisIndependent statistical analysis of Measurement of Relaxin Peptide in Multiple Sclerosis (MS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01909492).
- Measuring Brain Activity of School Age Children: Complete Statistical AnalysisIndependent statistical analysis of Measuring Brain Activity of School Age Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03407729).
- Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery.: Complete Statistical AnalysisIndependent statistical analysis of Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias: Complete Statistical AnalysisIndependent statistical analysis of Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Mechanisms of Antidepressant Non-Response in Late-Life Depression: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Antidepressant Non-Response in Late-Life Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01931202).
- Mechanisms of CBD for Chronic Pain: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of CBD for Chronic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04044729).
- Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01671605).
- Mechanisms of Hypoglycemia Associated Autonomic Failure: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Hypoglycemia Associated Autonomic Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678145).
- Mechanisms of Lipodystrophy in HIV-Infected Pateints: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Lipodystrophy in HIV-Infected Pateints: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00457665).
- Mechanisms of Non-Invasive Neuromodulation Interventions: Influence on Human Neurochemistry and Functional Connectivity: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Non-Invasive Neuromodulation Interventions: Influence on Human Neurochemistry and Functional Connectivity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Mechanistic Drivers of Acute PAPE Responsiveness: Muscle Architecture, Contractile Kinetics, and Excitability in a Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Mechanistic Drivers of Acute PAPE Responsiveness: Muscle Architecture, Contractile Kinetics, and Excitability in a Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- MEDALISTIndependent statistical analysis of A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MEDEXIndependent statistical analysis of A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MEDEXIndependent statistical analysis of Mindfulness-Based Stress Reduction, Health Education and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02665481).
- Medication Treatment for Depression in Nursing Home Residents: Complete Statistical AnalysisIndependent statistical analysis of Medication Treatment for Depression in Nursing Home Residents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00076622).
- MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity: Complete Statistical AnalysisIndependent statistical analysis of MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MedstarBC2Independent statistical analysis of MedStar Diabetes Pathway Chart Reviews: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03442595).
- MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC): Complete Statistical AnalysisIndependent statistical analysis of MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Melatonin in Smoke-induced Vascular Injury: Complete Statistical AnalysisIndependent statistical analysis of Melatonin in Smoke-induced Vascular Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02591238).
- Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02332928).
- Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MELTEMIIndependent statistical analysis of A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…